FDA approvaloutcome: successconf 1.00

aduhelm — FDA approval

$BIIB · BIOGEN INC.

Event date

June 7, 2021

1825 days ago

Sponsor runway

cash-flow +

$3.38B liquid

Evidence

“openFDA ORIG (TYPE 1) approval of ADUHELM — application BLA761178”

Source ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)

Ticker	Drug	Date	Outcome
$INCY	zynyz	2026-05-18	success
$INCY	jakafi xr	2026-05-01	success
$AXSM	auvelity	2026-04-30	success
$INCY	zynyz	2026-03-30	success
$BIIB	spinraza	2026-03-27	success
$CORT	lifyorli	2026-03-25	success
$RYTM	imcivree	2026-03-19	success
$ASND	yuviwel	2026-02-27	success
$BMRN	palynziq	2026-02-27	success
$ETON	desmoda	2026-02-25	success

Recent insider activity· ±90 days

17 insiders · 0 buys · 3 sells

Other

2021-09-01

MCDONNELL MICHAEL R

EVP, Chief Financial Officer

2,038 @ ——

Exercise

2021-09-01

MCDONNELL MICHAEL R

EVP, Chief Financial Officer

2,681 @ $338.24$907K

Tax

2021-09-01

MCDONNELL MICHAEL R

EVP, Chief Financial Officer

1,141 @ $338.24$386K

Exercise

2021-09-01

MCDONNELL MICHAEL R

EVP, Chief Financial Officer

3,324 @ $338.24$1.12M

Tax

2021-09-01

MCDONNELL MICHAEL R

EVP, Chief Financial Officer

1,441 @ $338.24$487K

Gift

2021-08-09

ALEXANDER SUSAN H

EVP Chief Legal Officer

523 @ ——

Grant

2021-07-01

HAWKINS WILLIAM A

Director

775 @ ——

Grant

2021-07-01

SHERWIN STEPHEN A

Director

775 @ ——

Grant

2021-07-01

Rowinsky Eric K

Director

775 @ ——

Grant

2021-07-01

Freire Maria C

Director

775 @ ——

Grant

2021-07-01

DORSA CAROLINE

Director

775 @ ——

Grant

2021-07-01

Posner Brian S

Director

775 @ ——

Grant

2021-07-01

Mantas Jesus B

Director

775 @ ——

Grant

2021-07-01

JONES WILLIAM D /CA/

Director

775 @ ——

Grant

2021-07-01

LEAMING NANCY

Director

775 @ ——

Grant

2021-07-01

Mulligan Richard

Director

775 @ ——

Exercise

2021-07-01

Kramer Robin

Chief Financial Officer

251 @ $348.92$88K

Tax

2021-07-01

Kramer Robin

Chief Financial Officer

74 @ $348.92$26K

Grant

2021-07-01

PAPADOPOULOS STELIOS

Director

1,275 @ ——

Grant

2021-07-01

DENNER ALEXANDER J

Director

775 @ ——

Sell

2021-06-07

Sandrock Alfred

Head of Research & Development

7,672 @ $440.00$3.38M

Sell

2021-06-07

Guindo Chirfi

Head of Glob Prod Strat & Com

3,087 @ $440.00$1.36M

Sell

2021-06-04

Posner Brian S

Director

360 @ $274.17$99K

Date	Insider	Action	Shares	Price	Value
2021-09-01	MCDONNELL MICHAEL REVP, Chief Financial Officer	Other	2,038	—	—
2021-09-01	MCDONNELL MICHAEL REVP, Chief Financial Officer	Exercise	2,681	$338.24	$907K
2021-09-01	MCDONNELL MICHAEL REVP, Chief Financial Officer	Tax	1,141	$338.24	$386K
2021-09-01	MCDONNELL MICHAEL REVP, Chief Financial Officer	Exercise	3,324	$338.24	$1.12M
2021-09-01	MCDONNELL MICHAEL REVP, Chief Financial Officer	Tax	1,441	$338.24	$487K
2021-08-09	ALEXANDER SUSAN HEVP Chief Legal Officer	Gift	523	—	—
2021-07-01	HAWKINS WILLIAM ADirector	Grant	775	—	—
2021-07-01	SHERWIN STEPHEN ADirector	Grant	775	—	—
2021-07-01	Rowinsky Eric KDirector	Grant	775	—	—
2021-07-01	Freire Maria CDirector	Grant	775	—	—
2021-07-01	DORSA CAROLINEDirector	Grant	775	—	—
2021-07-01	Posner Brian SDirector	Grant	775	—	—
2021-07-01	Mantas Jesus BDirector	Grant	775	—	—
2021-07-01	JONES WILLIAM D /CA/Director	Grant	775	—	—
2021-07-01	LEAMING NANCYDirector	Grant	775	—	—
2021-07-01	Mulligan RichardDirector	Grant	775	—	—
2021-07-01	Kramer RobinChief Financial Officer	Exercise	251	$348.92	$88K
2021-07-01	Kramer RobinChief Financial Officer	Tax	74	$348.92	$26K
2021-07-01	PAPADOPOULOS STELIOSDirector	Grant	1,275	—	—
2021-07-01	DENNER ALEXANDER JDirector	Grant	775	—	—
2021-06-07	Sandrock AlfredHead of Research & Development	Sell	7,672	$440.00	$3.38M
2021-06-07	Guindo ChirfiHead of Glob Prod Strat & Com	Sell	3,087	$440.00	$1.36M
2021-06-04	Posner Brian SDirector	Sell	360	$274.17	$99K

← All catalysts for $BIIB